Summary
This Form 8-K filing from Biogen Idec Inc. (BIIB), dated September 22, 2004, reports on the adoption of Rule 10b5-1 sales plans by two key executives. Mark Wiggins, Executive Vice President of Business Development, established a plan on August 3, 2004, for the sale of up to 55,000 shares (primarily from stock options) between October 4, 2004, and October 3, 2005. Additionally, William R. Rohn, Chief Operating Officer, entered into a separate Rule 10b5-1 sales plan on September 17, 2004. This plan allows for sales of up to 252,807 shares (all from stock options) over a longer period, with restrictions of 125,000 shares per quarter, depending on market conditions, and concluding by December 31, 2006. These disclosures are routine and aim to provide transparency regarding executive stock transactions.
Key Highlights
- 1Two Biogen Idec Inc. executives have adopted Rule 10b5-1 sales plans for their company stock.
- 2Mark Wiggins, EVP of Business Development, plans to sell up to 55,000 shares between October 2004 and October 2005.
- 3A portion of Mr. Wiggins' planned sales (50,000 shares) are derived from stock options.
- 4William R. Rohn, Chief Operating Officer, has a plan to sell up to 252,807 shares.
- 5Mr. Rohn's sales are subject to a quarterly limit of 125,000 shares and are scheduled to occur between November 2004 and December 2006.
- 6All shares designated for sale by Mr. Rohn are from stock options.
- 7Rule 10b5-1 plans allow insiders to pre-arrange stock sales at a time when they do not possess material non-public information.